JESSIE ZHAO: Open Payments
NPI 1144991241 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,262 in 79 payments from 18 companies in 2025. Trend: 2023 $1,313 · 2024 $2,095 · 2025 $2,262
Food & beverage: $2,262
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $406 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $392 |
| GlaxoSmithKline, LLC. | 14 | $371 |
| Gilead Sciences, Inc. | 8 | $187 |
| Agios Pharmaceuticals, Inc. | 2 | $179 |
| Exact Sciences Corporation | 6 | $136 |
| ABBVIE INC. | 4 | $109 |
| Ardelyx, Inc. | 3 | $82 |
| Merck Sharp & Dohme LLC | 4 | $81 |
| Novo Nordisk Inc | 5 | $74 |
Products named: EVENITY, JARDIANCE, PYRUKYND, TRELEGY ELLIPTA, AREXVY, Cologuard Collection Kit, LINZESS, IBSRELA.
Industry payments across NY — which companies pay providers there.
